• Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Mirati Therapeutics Inc

+ Add to Watchlist

26M:GR

14.398 EUR 0.203 1.39%

As of 02:00:12 ET on 09/19/2014.

Snapshot for Mirati Therapeutics Inc (26M)

Open: 14.398 Day's Range: 14.398 - 14.398 Volume: 0
Previous Close: 14.601 52wk Range: 11.592 - 17.968 1-Yr Rtn: -

Stock Chart for 26M

No chart data available.
  • 26M:GR 14.398
  • 1D
  • 1M
  • 1Y
14.601
Interactive 26M Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 26M

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (12/2014) -3.8500
Est. PEG Ratio -
Market Cap (M EUR) 194.87
Shares Outstanding (M) 13.53
30 Day Average Volume 6
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 26M

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for 26M

Mirati Therapeutics, Inc. is a biopharmaceutical company that discovers, develops, and commercializes novel therapeutics with an initial focus on cancer and infectious diseases.

Mark J GergenExec VP/COO/SecretaryCharles M BaumPresident/CEO
Isan ChenExec VP/Chief Medical OfcrJames ChristensenSenior VP/Chief Scientfic Ofcr
More Company Profile & Key Executives for 26M

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil